Results 161 to 170 of about 87,017 (286)

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Angiotensin-Converting Enzyme (ACE)-Inhibitor Activity of Novel Peptides Derived from Porcine Liver and Placenta. [PDF]

Molecules
Pearman NA, Morris GA, Smith AM.
europepmc   +1 more source

ACE inhibitor-related angioedema in a COVID-19 patient-a plausible contribution of the viral infection? [PDF]

Eur J Clin Pharmacol, 2021
Kuzemczak M, Kavvouras C, Alkhalil M, Osten M.   +3 more
europepmc   +1 more source

Angiotensin-Converting Enzyme (ACE) Inhibitors and Pancreatitis: A Potential Dose-dependent Relationship

, 2020
Murtaza Hussain, Smit Deliwala, Anoosha Ponnapalli, Viraj Modi, Ashok Kanagula, Mamoon Elbedawi, Ghassan Bachuwa   +6 more
openalex   +2 more sources

ACE inhibitors and regression of left ventricular hypertrophy [PDF]

, 1992
Brian W. Gilbert
openalex   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Comparative Evaluation of ARB Monotherapy and SGLT2/ACE Inhibitor Combination Therapy in the Renal Function of Diabetes Mellitus Patients: A Retrospective, Longitudinal Cohort Study. [PDF]

Int J Mol Sci
Ngai AW, Baig A, Zia M, Arca-Contreras K, Haque NU, Livetsky V, Rokicki M, Sukhram SD.   +7 more
europepmc   +1 more source

Angioedema, ACE inhibitor and COVID-19. [PDF]

BMJ Case Rep, 2020
Grewal E, Sutarjono B, Mohammed I.
europepmc   +1 more source

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients. [PDF]

Ren Fail, 2021
Daoud A, Ali H, Rao V, Rohan V, Soliman K.   +4 more
europepmc   +1 more source

Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT [PDF]

, 2009
Salvatore De Cosmo, Nicola Motterlini, Sabrina Prudente, Fabio Pellegrini, Roberto Trevisan, Antonio Bossi, Giuseppe Remuzzi, Vincenzo Trischitta, Piero Ruggenenti, on behalf of the BENEDICT Study Group   +9 more
openalex   +1 more source